Quoin Pharmaceuticals‘ Q4 Earnings Report Unveiled
On March 13, 2024, Quoin Pharmaceuticals (NASDAQ: QNRX) disclosed its Q4 earnings, shedding light on important details for investors to take note of:
Earnings Highlights:
Quoin Pharmaceuticals outperformed projected earnings by 10.0%, with an EPS of $-2.08, exceeding the estimated $-2.31.
Revenue showed no change compared to the same period last year.
Previous Earnings Track Record:
In the prior quarter, the company surpassed EPS forecasts by $0.77, yet experienced an 8.0% drop in share price the following day.
For a more comprehensive insight into Quoin Pharmaceuticals’ earnings reports and performance, investors can access their earnings calendar.
This information was gathered from a variety of sources, including MarketBeat, Nasdaq, and Quoin Pharmaceuticals’ official news release.
QNRX Stock Price Update: March 13, 2024 – Bearish Trend Reversed in After-Hours Trading
On March 13, 2024, QNRX stock experienced a slight drop in price, closing at $1.16, which was a decrease of $0.03 or 2.52% from the previous market close. This puts the stock trading near the bottom of its 52-week range and below its 200-day simple moving average, indicating a bearish trend in its price momentum.
However, there was a slight uptick in the stock’s performance in after-hours trading, with the price rising by $0.03. This could potentially indicate some positive sentiment among investors after the market closed.
QNRX Stock Performance Analysis: Positive Growth in Net Income and EPS
On March 13, 2024, QNRX stock showed some interesting performances based on the data available from CNN Money. According to the data, QNRX reported a net income of -$9.34 million over the past year, which was a significant improvement from the previous year. In the third quarter of the year, the net income was reported at -$1.92 million, showing a 56.49% increase since last year and a 7.81% increase since the previous quarter. Similarly, the earnings per share (EPS) figures also showed positive growth for QNRX. The EPS was reported at -$23.31 over the past year, which increased by 97.13% since the previous year. In the third quarter, the EPS was reported at -$1.95, showing an 18.02% increase since the previous quarter. Overall, the data suggests that QNRX has been able to improve its financial performance over time, with both net income and EPS showing positive growth trends. Investors may want to keep an eye on QNRX stock to see how these trends continue in the future.
